Mesoblast (MESO) Stock: Buy, Sell, or Hold?
MESO - Mesoblast Limited American Depositary Shares
$15.16
-0.51 (-3.25%)
▼
5d:
+23.45%
30d:
+5.87%
90d:
+4.77%
WAIT
LOW Confidence
Analysis Updated: Oct 30, 2026 12:00 AM ET
Earnings: Sep 04, 2026
0d
Get Alerted When MESO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MESO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MESO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MESO is currently trading at $15.16, which is considered extended relative to its 30-day fair value range of $12.91 to $15.04. From a valuation perspective, the stock is trading at a discount (Forward PE: -252.7) compared to its historical average (206.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MESO is showing sideways momentum. Immediate support is located at $11.89, while resistance sits at $15.82. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: MESO scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.00 (+144.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MESO is showing sideways momentum. Immediate support is located at $11.89, while resistance sits at $15.82. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: MESO scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.00 (+144.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.91 -
$15.04
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
28.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 144.1% below Wall St target ($37.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$12.91 -
$15.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.89
Resistance Level
$15.82
Current Trend
Sideways
Technical data as of
Oct 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-252.67
Wall Street Target
$37.00
(+144.1%)
Revenue Growth (YoY)
390.7%
Profit Margin
-47.8%
PE vs Historical
-252.7 vs 206.7
CHEAP
Share & Embed Analysis
Last updated: October 31, 2026 9:43 PM ET
Data refreshes hourly during market hours. Next update: 10:43 PM
Data refreshes hourly during market hours. Next update: 10:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MESO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$867 | 35 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 39 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 50 HOLD |
|
AVTX
Avalo Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 50 HOLD |
